KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Operating Expenses: 2010-2015

Historic Operating Expenses for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Sep 2015 value amounting to $24.1 million.

  • Biocryst Pharmaceuticals' Operating Expenses rose 62.64% to $24.1 million in Q3 2015 from the same period last year, while for Sep 2015 it was $86.5 million, marking a year-over-year increase of 55.37%. This contributed to the annual value of $59.4 million for FY2014, which is 23.58% up from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Operating Expenses of $24.1 million as of Q3 2015, which was up 17.80% from $20.5 million recorded in Q2 2015.
  • Over the past 5 years, Biocryst Pharmaceuticals' Operating Expenses peaked at $24.1 million during Q3 2015, and registered a low of $8.9 million during Q2 2013.
  • Moreover, its 3-year median value for Operating Expenses was $15.9 million (2013), whereas its average is $16.0 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Operating Expenses slumped by 39.76% in 2011 and then soared by 96.02% in 2015.
  • Quarterly analysis of 4 years shows Biocryst Pharmaceuticals' Operating Expenses stood at $16.3 million in 2011, then reached $16.9 million in 2013, then rose by 21.90% to $20.6 million in 2014, then soared by 62.64% to $24.1 million in 2015.
  • Its Operating Expenses was $24.1 million in Q3 2015, compared to $20.5 million in Q2 2015 and $21.3 million in Q1 2015.